| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 224,082 | 185,176 | 177,104 | 189,121 | | Cost of Revenue | 117,373 | 98,845 | 95,243 | 107,752 | | | Gross Profit | 106,709 | 86,331 | 81,861 | 81,369 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 64,033 | 57,169 | 55,980 | 56,048 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 42,676 | 29,162 | 25,881 | 25,321 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (214) | 270 | 348 | (324) | | Earnings Before Interest And Taxes | 42,462 | 29,432 | 26,229 | 24,997 | | Interest Expense | 4,311 | 4,477 | 4,571 | 5,493 | | Income Before Tax | 38,151 | 24,955 | 21,658 | 19,504 | | Income Tax Expense | 12,467 | 8,098 | 8,320 | 18,449 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 25,684 | 16,857 | 13,338 | 1,055 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 25,684 | 16,857 | 13,338 | 1,055 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $25,684 | $16,857 | $13,338 | $1,055 |
|
0.51% Nasdaq 
Income Statement
